Sulfur amino acid-free diet results in increased glutamate in human midbrain: A pilot magnetic resonance spectroscopic study

Nutrition

Volumn 28, Issue 3, 2012, Pages 235-241

  Park, Youngja ^a   Zhao, Tiejun ^a   Miller, Nana Gletsu ^a   Kim, Seoung Bum ^b   Accardi, Carolyn Jonas ^a   Ziegler, Thomas R ^a   Hu, Xiaoping ^a   Jones, Dean P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Korea University   (South Korea)

Author keywords

Amino acid metabolism; Brain metabolism; Glutathione; Nutritional assessment; Oxidative stress; Protein malnutrition

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; CREATINE PHOSPHATE; CREATININE; CYSTEINE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLYCEROPHOSPHORYLCHOLINE; GUANIDINOACETIC ACID; INOSITOL; METHIONINE; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; PHOSPHORYLCHOLINE; SULFUR AMINO ACID; TAURINE;

ADULT; AMINO ACID DEFICIENCY; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CORRELATION ANALYSIS; FEMALE; FOOD COMPOSITION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; MESENCEPHALON; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITIONAL ASSESSMENT; PARIETAL LOBE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; STATISTICAL MODEL; VOLUNTEER;

ADOLESCENT; ADULT; AMINO ACIDS, SULFUR; CYSTEINE; DIET; FEMALE; GLUTAMIC ACID; GLUTATHIONE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MALNUTRITION; MESENCEPHALON; METHIONINE; MULTIVARIATE ANALYSIS; NUTRITION ASSESSMENT; PARIETAL LOBE; PILOT PROJECTS; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84856483666     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.05.007     Document Type: Article

References (48)

1. Doig G.S., Simpson F. Early enteral nutrition in the critically ill: do we need more evidence or better evidence?. Curr Opin Crit Care 2006, 12:126-130.
2. Soeters P.B., Reijven P.L., van Bokhorst-de van der Schueren M.A., Schols J.M., Halfens R.J., Meijers J.M., van Gemert W.G. A rational approach to nutritional assessment. Clin Nutr 2008, 27:706-716.
3. van de Poll M.C., Dejong C.H., Soeters P.B. Adequate range for sulfur-containing amino acids and biomarkers for their excess: lessons from enteral and parenteral nutrition. J Nutr 2006, 136(6, suppl):1694S-1700S.
4. Ziegler T.R. Parenteral nutrition in the critically ill patient. N Engl J Med 2009, 361:1088-1097.
5. Argaman Z., Young V.R., Noviski N., Castillo-Rosas L., Lu X.M., Zurakowski D., et al. Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit Care Med 2003, 31:591-597.
6. Chen C.L., Fei Z., Carter E.A., Lu X.M., Hu R.H., Young V.R., et al. Metabolic fate ofextrahepatic arginine in liver after burn injury. Metabolism 2003, 52:1232-1239.
7. Kurpad A.V., Regan M.M., Raj T., Vasudevan J., Kuriyan R., Gnanou J., Young V.R. Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique. Am J Clin Nutr 2003, 77:101-108.
8. Jonas C.R., Puckett A.B., Jones D.P., Griffith D.P., Szeszycki E.E., Bergman G.F., et al. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am JClin Nutr 2000, 72:181-189.
9. Davis C.D., Milner J.A. Biomarkers for diet and cancer prevention research: potentials and challenges. Acta Pharmacol Sin 2007, 28:1262-1273.
10. Davis C.D., Milner J.A. Molecular targets for nutritional preemption of cancer. Curr Cancer Drug Targets 2007, 7:410-415.
11. German J.B., Watkins S.M., Fay L.B. Metabolomics in practice: emerging knowledge to guide future dietetic advice toward individualized health. JAm Diet Assoc 2005, 105:1425-1432.
12. Flagg E.W., Coates R.J., Jones D.P., Eley J.W., Gunter E.W., Jackson B., Greenberg R.S. Plasma total glutathione in humans and its association with demographic and health-related factors. Br J Nutr 1993, 70:797-808.
13. Go Y.M., Jones D.P. Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta 2008, 1780:1273-1290.
14. Jones D.P. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 2002, 348:93-112.
15. Jones D.P. Redefining oxidative stress. Antioxid Redox Signal 2006, 8:1865-1879.
16. Stipanuk M.H., Dominy J.E. Surprising insights that aren't so surprising inthe modeling of sulfur amino acid metabolism. Amino Acids 2006, 30:251-256.
17. Stipanuk M.H., Dominy J.E., Lee J.I., Coloso R.M. Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism. J Nutr 2006, 136(6, suppl):1652S-1659S.
18. Griffin J.L., Salek R.M. Metabolomic applications to neuroscience: more challenges than chances?. Expert Rev Proteomics 2007, 4:435-437.
19. Jones D.P., Mody V.C., Carlson J.L., Lynn M.J., Sternberg P. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med 2002, 33:1290-1300.
20. Moriarty S.E., Shah J.H., Lynn M., Jiang S., Openo K., Jones D.P., Sternberg P. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med 2003, 35:1582-1588.
21. Yeh M.Y., Burnham E.L., Moss M., Brown L.A. Chronic alcoholism alters systemic and pulmonary glutathione redox status. Am J Respir Crit Care Med 2007, 176:270-276.
22. Ziegler T.R., Panoskaltsus-Mortari A., Gu L.H., Jonas C.R., Farrell C.L., Lacey D.L., et al. Regulation of glutathione redox status in lung and liver by conditioning regimens and keratinocyte growth factor in murine allogeneic bone marrow transplantation. Transplantation 2001, 72:1354-1362.
23. Clarke D.D., Sokoloff L. Basic neurochemistry: molecular, cellular and medical aspects 1999, Lippincott-Raven, Philadelphia.
24. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 2000, 62:649-671.
25. Dringen R. Glutathione metabolism and oxidative stress in neurodegeneration. Eur J Biochem 2000, 267:4903.
26. Hansen J.M., Go Y.M., Jones D.P. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol 2006, 46:215-234.
27. Jiang S., Moriarty-Craige S.E., Orr M., Cai J., Sternberg P., Jones D.P. Oxidant-induced apoptosis in human retinal pigment epithelial cells: dependence on extracellular redox state. Invest Ophthalmol Vis Sci 2005, 46:1054-1061.
28. Jones D.P., Go Y.M., Anderson C.L., Ziegler T.R., Kinkade J.M., Kirlin W.G. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J 2004, 18:1246-1248.
29. Kemp M., Go Y.M., Jones D.P. Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology. Free Radic Biol Med 2008, 44:921-937.
30. Kanowski M., Kaufmann J., Braun J., Bernarding J., Tempelmann C. Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magn Reson Med 2004, 51:904-912.
31. Mierisova S., Ala-Korpela M. MR spectroscopy quantitation: a review of frequency domain methods. NMR Biomed 2001, 14:247-259.
32. Opstad K.S., Provencher S.W., Bell B.A., Griffiths J.R., Howe F.A. Detection of elevated glutathione in meningiomas by quantitative invivo 1H MRS. Magn Reson Med 2003, 49:632-637.
33. Terpstra M., Henry P.G., Gruetter R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med 2003, 50:19-23.
34. Terpstra M., Vaughan T.J., Ugurbil K., Lim K.O., Schulz S.C., Gruetter R. Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia. Magma 2005, 18:276-282.
35. Zhao T., Heberlein K., Jonas C., Jones D.P., Hu X. New double quantum coherence filter for localized detection of glutathione invivo. Magn Reson Med 2006, 55:676-680.
36. Provencher S.W. Automatic quantitation of localized invivo 1H spectra with LCModel. NMR Biomed 2001, 14:260-264.
37. Jones D.P., Park Y., Gletsu-Miller N., Liang Y., Yu T., Accardi C.J., Ziegler T.R. Dietary sulfur amino acid effects on fasting plasma cysteine/cystine redox potential in humans. Nutrition 2011, 27:199-205.
38. Hersch S.M., Gevorkian S., Marder K., Moskowitz C., Feigin A., Cox M., et al. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology 2006, 66:250-252.
39. Siesjo B.K., Folbergrova J., MacMillan V. The effect of hypercapnia upon intracellular pH in the brain, evaluated by the bicarbonate-carbonic acid method and from the creatine phosphokinase equilibrium. J Neurochem 1972, 19:2483-2495.
40. Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. J Proteome Res 2007, 6:469-479.
41. Serkova N.J., Niemann C.U. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev Mol Diagn 2006, 6:717-731.
42. Shulaev V. Metabolomics technology and bioinformatics. Brief Bioinform 2006, 7:128-139.
43. Blanco R.A., Ziegler T.R., Carlson B.A., Cheng P.Y., Park Y., Cotsonis G.A., et al. Diurnal variation in glutathione and cysteine redox states in human plasma. Am J Clin Nutr 2007, 86:1016-1023.
44. Fitzmaurice P.S., Ang L., Guttman M., Rajput A.H., Furukawa Y., Kish S.J. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease. Mov Disord 2003, 18:969-976.
45. Jansen J.F., Backes W.H., Nicolay K., Kooi M.E. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006, 240:318-332.
46. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989, 2:1547-1558.
47. Sato H., Shiiya A., Kimata M., Maebara K., Tamba M., Sakakura Y., et al. Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem 2005, 280:37423-37429.
48. Sato H., Tamba M., Okuno S., Sato K., Keino-Masu K., Masu M., Bannai S. Distribution of cystine/glutamate exchange transporter, system x(c)-, in the mouse brain. J Neurosci 2002, 22:8028-8033.